4//SEC Filing
Hagopian Henry III 4
Accession 0001104659-23-005480
CIK 0001477845other
Filed
Jan 19, 7:00 PM ET
Accepted
Jan 20, 5:42 PM ET
Size
5.5 KB
Accession
0001104659-23-005480
Insider Transaction Report
Form 4
Hagopian Henry III
Chief Financial Officer
Transactions
- Award
Stock Option (right to buy)
2023-01-18+7,672→ 7,672 totalExercise: $13.17Exp: 2033-01-18→ Common Stock (7,672 underlying)
Footnotes (1)
- [F1]The stock option shall vest in eight consecutive quarterly installments of 1,918 shares each on the 18th day of April, July, October and January of each year, commencing April 18, 2023, and continuing through January 18, 2025.
Documents
Issuer
Annovis Bio, Inc.
CIK 0001477845
Entity typeother
Related Parties
1- filerCIK 0001821822
Filing Metadata
- Form type
- 4
- Filed
- Jan 19, 7:00 PM ET
- Accepted
- Jan 20, 5:42 PM ET
- Size
- 5.5 KB